16 not yet recruiting, 12 completed, 9 recruiting, 3 unknown. 9 Not applicable, 7 Phase 4, 5 Phase 3, 2 Phase 2, 1 Phase 1.
Follow HELICOBACTER PYLORI INFECTIONS: new trials by email Literature Review of HELICOBACTER PYLORI INFECTIONS trials Research Report on HELICOBACTER PYLORI INFECTIONS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori Eradication Vonoprazan-Amoxicillin Dual Therapy, Vonoprazan-Tetracycline Dual Therapy, Vonoprazan-Minocycline Dual Therapy - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | Qilu Hospital of Shandong University | 492 | 2026-09-01 | 2026-08-11 |
| Feasibility and Performance of FFPE qPCR for Detection of Clarithromycin Resistance in Helicobacter Pylori q-PCR on FFPE gastric biopsies - HELICOBACTER PYLORI INFECTIONS | Not yet recruiting | Clinique Bizet | 250 | 2026-09-01 | 2026-09-15 | |
| Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression Keverprazan Hydrochloride 20 mg TID, Minocycline 100 mg (10-Day Regimen), Keverprazan Hydrochloride 20 mg BID - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | Qilu Hospital of Shandong University | 316 | 2026-08-01 | 2026-08-06 |
| The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori Anaprazole Sodium enteric-coated tablet, Esomeprazole magnesium enteric-coated tablets - HELICOBACTER PYLORI INFECTIONS | Phase 3 | Not yet recruiting | Xuanzhu Biopharmaceutical Co., Ltd. | 556 | 2026-06-10 | 2026-05-26 |
| Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Levofloxacin-Based Sequential Therapy, Bismuth-Based Quadruple Therapy - HELICOBACTER PYLORI INFECTIONS | Not applicable | Not yet recruiting | University of Health Sciences Lahore | 90 | 2026-06-01 | 2026-05-08 |
| Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing Personalized treatment based on the results of fecal antimicrobial resistance gene testing, Conventional Quadruple Therapy - HELICOBACTER PYLORI INFECTIONS, Rescue Therapy for Helicobacter Pylori | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 531 | 2026-05-12 | 2026-04-16 |
| Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori Eradication Bismuth Add-on to Vonoprazan Dual Therapy, Vonoprazan dual therapy - HELICOBACTER PYLORI INFECTIONS | Phase 3 | Recruiting | National Taiwan University Hospital | 990 | 2026-04-08 | 2026-05-08 |
| Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound Peptic Ulcer Disease, HELICOBACTER PYLORI INFECTIONS | Not yet recruiting | Assiut University | 230 | 2026-04-01 | 2026-03-09 | |
| Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study Antimicrobial susceptibility testing - HELICOBACTER PYLORI INFECTIONS | Completed | Nanjing First Hospital, Nanjing Medical University | 7227 | 2026-03-01 | 2026-04-09 | |
| Fecal Molecular Susceptibility-guided Hp First-line Therapy 7-day fecal molecular susceptibility-guided therapy, 14-day fecal molecular susceptibility-guided therapy - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | Shanghai Zhongshan Hospital | 544 | 2026-02-28 | 2026-02-12 |
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection Vonoparazan, Vitamin D, Probiotic - HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection | Phase 2 | Recruiting | Tanta University | 132 | 2026-02-15 | 2026-09-09 |
| Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection zinc sulfate, Vonoprazan + amoxicillin + clarithromycin, proton pump inhibitor + amoxicillin - HELICOBACTER PYLORI INFECTIONS | Phase 3 | Recruiting | Tanta University | 88 | 2026-02-01 | 2026-09-09 |
| Registry for the Management of Helicobacter Pylori Infection in Shandong Province Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstance, not involve any intervention procedure. - HELICOBACTER PYLORI INFECTIONS | Recruiting | Yueyue Li | 10000 | 2026-02-01 | 2026-04-02 | |
| miRNA in Pediatric Gastritis miRNA gene expression - HELICOBACTER PYLORI INFECTIONS | Not applicable | Not yet recruiting | Benha University | 100 | 2026-01-20 | 2025-12-24 |
| Endoscopic Screening of Asymptomatic Patients for Helicobacter Pylori, Intestinal Metaplasia, and Barrett's Mucosa During Screening Colonoscopy HELICOBACTER PYLORI INFECTIONS, Intestinal Metaplasia | Recruiting | Sigmund Freud PrivatUniversitat | 1000 | 2025-12-16 | 2026-03-09 | |
| Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe Biopsies - HELICOBACTER PYLORI INFECTIONS, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | Not yet recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 100 | 2025-12-15 | 2025-12-18 | |
| Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori） Tegoprazan 50 mg, Amoxicillin 1 g TID, Amoxicillin 1.5 g BID - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | First People's Hospital of Hangzhou | 240 | 2025-11-20 | 2025-11-21 |
| Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication 7-day triple therapy, 14-day dual therapy - HELICOBACTER PYLORI INFECTIONS | Completed | Yueyue Li | 508 | 2025-11-01 | 2026-01-12 | |
| Lignin in Treatment of Helicobacter Pylori Infection Hydrolyzed Lignin, Placebo - HELICOBACTER PYLORI INFECTIONS | Phase 3 | Completed | Zagazig University | 70 | 2025-10-31 | 2026-10-01 |
| Feasibility Study to Diagnose Helicobacter Pylori in the Paediatric Population Using Non-invasive Fecal Analysis Gastric biopsies, Stool sampling - HELICOBACTER PYLORI INFECTIONS | Recruiting | Poitiers University Hospital | 188 | 2025-10-07 | 2025-11-20 |
Showing 20 of 42. Sign in to see all of them.
Stomach Neoplasms (3) · Gastritis, Atrophic (2) · Metabolic Syndrome (2) · Colitis, Ulcerative (1) · Communicable Diseases (1) · Dyspepsia (1) · Gastritis (1) · Gastrointestinal Diseases (1) · Helicobacter Infections (1) · Hyperprolactinemia (1) · Inflammatory Bowel Diseases (1) · Osteoporosis (1) · Peptic Ulcer (1) · Purpura, Thrombocytopenic, Idiopathic (1) · cyclopia sequence (1)
Digestive System Diseases (7) · Gastrointestinal Diseases (6) · Stomach Diseases (5) · Gastroenteritis (4) · Digestive System Neoplasms (3) · Gastrointestinal Neoplasms (3) · Metabolic Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Nutritional and Metabolic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Gastritis (2) · Glucose Metabolism Disorders (2) · Hyperinsulinism (2) · Infections (2)
Amoxicillin (8) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (4) · BID protein, human (2) · Clarithromycin (2) · Esomeprazole (2) · Proton Pump Inhibitors (2) · tegoprazan (2) · Absorptiometry, Photon (1) · Berberine (1) · Biopsy (1) · Bismuth (1) · Clinical Protocols (1) · Endoscopic Mucosal Resection (1) · Gastroscopy (1) · Metronidazole (1)
Assiut University (3) · Nanjing First Hospital, Nanjing Medical University (3) · National Taiwan University Hospital (2) · Qilu Hospital of Shandong University (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Seoul National University Bundang Hospital (2) · Tanta University (2) · Yueyue Li (2) · Al-Mustansiriyah University (1) · Asan Medical Center (1) · Benha University (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Chang Gung Memorial Hospital (1) · Clinique Bizet (1) · First People's Hospital of Hangzhou (1)
China (13) · Egypt (4) · Taiwan (4) · South Korea (3) · France (2) · Austria (1) · Guadeloupe (1) · Iran (1) · Iraq (1) · Jordan (1) · Latvia (1) · Portugal (1) · Singapore (1)
Ji Yong Ahn, Professor (1) · Jin Young Park, PhD (1) · Jyh-Ming Liou, MD, PhD (1) · Lee Guan Lim (1) · Manal Khalid Abdulridha, proffessor at Mustansiriyah (1) · Marcis Leja, MD, PhD (1) · Mei-Jyh Chen, MD, PhD (1) · Nayoung Kim, M.D., Ph.D. (1)
PMID 15907550, PMID 17067919, PMID 18237386, PMID 21923713, PMID 23566268, PMID 24890952, PMID 25439074, PMID 26940296, PMID 28098408, PMID 28456631, PMID 28558708, PMID 28602053, PMID 28801429, PMID 28932364, PMID 29145971, PMID 29511549, PMID 30893536, PMID 30944675, PMID 32052404, PMID 32283700, PMID 32407890, PMID 32946931, PMID 33975689, PMID 34519690, PMID 34942310, PMID 34997989, PMID 35474447, PMID 35531944, PMID 35654291, PMID 35660509, PMID 35884067, PMID 35929980, PMID 36235778, PMID 36240980, PMID 36579940, PMID 36729890, PMID 36765621, PMID 37086739, PMID 37731836, PMID 38036941, PMID 40341536, PMID 40762368, PMID 40820207, PMID 40869058, PMID 40984972, PMID 42537821, PMID 9014926